Table 3.
Binary logistic regression analysis predicting likelihood of receiving PTSD and CPTSD diagnosis across age groups.
| PTSD % (n) | B | SE | OR (95% CI) | CPTSD % (n) | B | SE | OR (95% CI) | |
|---|---|---|---|---|---|---|---|---|
| Ireland | ||||||||
| 18–25 | 8.0 (10) | 0.60 | 0.56 | 1.82 (0.60–5.52) | 8.0 (10) | −.02 | 0.47 | 0.976 (0.38–2.50) |
| 25–35 | 7.3 (15) | 0.50 | 0.53 | 1.65 (0.58–5.66) | 4.9 (10) | −0.55 | 0.47 | 0.537 (0.23–1.45) |
| 35–44 | 3.8 (9) | −0.20 | 0.57 | 0.82 (0.27–2.50) | 7.9 (19) | −0.03 | 0.42 | 0.965 (0.42–2.20) |
| 44–54 | 4.1 (8) | −0.10 | 0.53 | 0.90 (0.29–2.82) | 9.7 (19) | 0.19 | 0.42 | 1.21 (0.52–2.82) |
| 55–65 | 2.8 (4) | −0.51 | 0.68 | 0.60 (0.16–2.29) | 8.3 (12) | 0.02 | 0.46 | 0.600 (0.15–2.29) |
| 65+ | 4.5 (5) | – | – | – | 8.2 (9) | – | – | – |
| US | ||||||||
| 18–25 | 4.9 (9) | 1.1 | 0.68 | 3.13 (0.82–11.92) | 1.6 (3) | −0.18 | 0.80 | 0.83 (0.17–3.93) |
| 25–35 | 6.2 (23) | 1.4 | 0.62 | 4.19 (1.23–14.23) | 4.6 (17) | 0.92 | 0.59 | 2.50 (0.78–7.89) |
| 35–44 | 2.9 (10) | 0.6 | 0.67 | 1.79 (0.48–6.67) | 4.3 (15) | 0.85 | 0.59 | 2.33 (0.72–7.47) |
| 44–54 | 4.5 (15) | 1.0 | 0.64 | 2.91 (0.82–10.27) | 6.2 (21) | 1.2 | 0.58 | 3.32 (1.06–10.35) |
| 55–65 | 0.5 (2) | −1.2 | 0.95 | 0.28 (0.04–1.82) | 2.5 (10) | 0.26 | 0.62 | 1.30 (0.38–4.40) |
| 65+ | 1.6 (3) | – | – | – | 2.2 (4) | – | – | – |
| Israel | ||||||||
| 18–25 | 10.7 (17) | 0.87 | 0.66 | 2.39 (0.67–8.87) | 7.5 (12) | 0.91 | 0.78 | 2.49 (0.54–11.45) |
| 25–35 | 5.0 (13) | 0.05 | 0.67 | 1.06 (0.29–3.83) | 6.2 (16) | 0.70 | 0.76 | 2.00 (0.45–8.97) |
| 35–44 | 5.0 (10) | 0.06 | 0.68 | 1.05 (0.28–3.97) | 5.5 (11) | 0.57 | 0.78 | 1.79 (0.38–8.28) |
| 44–54 | 9.1 (15) | 0.70 | 0.65 | 2.00 (0.56–7.16) | 3.0 (5) | −0.05 | 0.85 | 0.953 (0.18–5.04) |
| 55–65 | 5.7 (9) | 0.20 | 0.68 | 1.21 (0.31–4.62) | 1.9 (3) | −0.53 | 0.93 | 0.580 (0.09–3.62) |
| 65+ | 4.8 (3) | – | – | – | 3.2 (2) | – | – | – |
| UK | ||||||||
| 18–25 | 5.6 (3) | 1.4 | 0.93 | 4.35 (0.70–26.7) | 29.6 (16) | 2.0 | 0.47 | 7.47 (2.98–18.77) |
| 25–35 | 7.2 (16) | 1.7 | 0.76 | 5.77 (1.31–25.5) | 17.6 (39) | 1.3 | 0.40 | 3.80 (1.72–8.40) |
| 35–44 | 7.3 (14) | 1.8 | 0.76 | 5.82 (1.30–26.0) | 19.3 (37) | 1.4 | 0.41 | 4.23 (1.90–9.40) |
| 44–54 | 3.5 (8) | 0.99 | 0.79 | 2.70 (0.56–12.9) | 12.8 (29) | 0.95 | 0.41 | 2.60 (1.15–5.85) |
| 55–65 | 6.3 (13) | 1.6 | 0.76 | 4.95 (1.10–22.3) | 4.3 (7) | −0.48 | 0.53 | 0.621 (0.22–1.75) |
| 65+ | 1.3 (2) | – | – | – | 5.3 (8) | – | – | – |
Note: Statistically significant (p < 0.05) effects are in bold.
Abbreviations: B, unstandardized beta value; OR (95% CI), odds ratio with 95% confidence intervals; SE, standard error of beta.